Axogen, Inc. (AXGN) Stock

About Axogen, Inc.

Axogen, Inc. (AXGN) stock trades at $38.06 with a market capitalization of $2.23B. The stock is valued at a negative price-to-earnings (P/E) ratio of -55.71, reflecting a net loss over the last twelve months, price-to-book of 7.82, price-to-sales of 8.05. Over the past 52 weeks the stock has ranged between $15.27 and $52.91, and currently trades 28.1% below its 52-week high.

On profitability, Axogen, Inc. generates a return on equity (ROE) of -17.88% (negative, reflecting a net loss), return on capital employed of -4.68%, an operating margin of -3.79%, a net profit margin of -13.36%.

Axogen, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Axogen, Inc. reported revenue of $41.0M rising to $225.0M, a change of +448.8% across 10 years. Compounded, revenue has grown 15.0% a year over five years, 17.4% over three, 20.3% over the last twelve months. Net profit fell to $-16.0M.

Operating margin went from -19.8% in 2016 to -3.5% in 2025, a gain of 16.3 percentage points. The most recent net margin is -13.36%. On a trailing twelve-month basis to Jun '26, revenue is $251.0M and net profit $-34.0M.

Borrowings rose from $24.0M to $68.0M, cash from operations was $1.0M in the latest year, positive in 2 of the last 10.

Return on equity has averaged -19.5% over five years, and was -12.4% in the most recent year.

The share price itself has compounded at 17.4% a year over five years, 68.5% over three, 351.2% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Axogen, Inc. (AXGN) — frequently asked questions